Navigation Links
November is Lung Cancer Month: Know the Latest Information About This Deadliest of Cancers
Date:10/27/2009

INDIANAPOLIS, Oct. 27 /PRNewswire-FirstCall/ -- Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected to be diagnosed this year.(1) It is also estimated that lung cancer will cause 159,000 deaths in the United States this year - more than the total number of deaths resulting from breast, colon and prostate cancers combined.(1) Still, lung cancer lags far behind other cancers in both awareness and research funding, and, partly due to its connection with smoking, there can be a stigma attached to the disease.(2)

But there is hope for lung cancer patients. According to Richard Gaynor, M.D., vice president of oncology product development and medical affairs at Eli Lilly and Company, a leader in thoracic cancer treatment, "Researchers have made important strides in the last decade in lung cancer prevention, detection and treatment. We know that secondary smoke is detrimental.(3) We have better X-rays and spiral CT scans to detect lung cancer earlier on. And we know that where treatment is concerned, lung cancer, like breast cancer, can benefit from a tailored approach."

In the past, oncologists have used similar approaches to treatment based on lung cancer diagnosis, staging and prognosis.(4) But advances in tailored treatment options may help oncologists choose which patients could be more likely to benefit from certain therapies.

"While our work is far from finished, we do have a better understanding of lung cancer today, and patients can benefit," said Dr. Gaynor.

Prevalence and Prognosis

Lung cancer can affect any adult, including nonsmokers. Since 1985, it has risen to be the world's most common form of cancer, and an estimated 219,440 more Americans are expected to be diagnosed this year.(5) The chance that a man will develop lung cancer is about 1 in 13, and for a woman it is approximately 1 in 16.(1) Nearly 70 percent of people diagnosed with
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Medco to Present at November 2009 Investor Conferences
2. Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009
3. Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009
4. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
5. Masimo to Report Third Quarter 2009 Financial Results on November 3, 2009
6. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
7. CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010
8. The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA -- Hynes Convention Center October 31 -- November 3, 2009
9. Opportunities to Highlight Type 1 Diabetes in November
10. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
11. CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015   HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of advanced ... Godshall , is scheduled to present at the Bank of ... Las Vegas on Thursday, May 14, 2015, at ... webcast of the Company,s presentation at the conference will be ...
(Date:5/4/2015)... Calif. , May 4, 2015  Isis Pharmaceuticals, ... exclusive license agreement with Bayer HealthCare (Bayer) to develop ... thrombosis. Under the terms of the agreement, Isis is ... payments, including an immediate $100 million up-front payment and ... following a Phase 2 study in patients with compromised ...
(Date:5/4/2015)... 4, 2015 MEI Pharma, Inc. (Nasdaq: ... the clinical development of novel therapies for cancer, ... of the Company,s investigational drug candidate ME-344 in ... combined with a tyrosine-kinase inhibitor (TKI). In addition, ... a potent inhibitor of mitochondrial oxidative phosphorylation (OXPHOS) ...
Breaking Medicine Technology:HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5
...  A number of large pharmaceutical and biotech companies are ... genomic technologies and molecular biology segments will boost the ... MicroRNA is set to unveil a new era in ... New analysis from Frost & Sullivan ( ...
... 23, 2012 Reportlinker.com announces that a ... its catalogue: Pharmaceuticals ... Guide http://www.reportlinker.com/p0191857/Pharmaceuticals---Global-Group-of-Eight-G8-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceu ... (G8) Industry Guide is an essential resource ...
Cached Medicine Technology:MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan 2MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan 3MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan 4Pharmaceuticals - Global Group of Eight (G8) Industry Guide 2Pharmaceuticals - Global Group of Eight (G8) Industry Guide 3Pharmaceuticals - Global Group of Eight (G8) Industry Guide 4Pharmaceuticals - Global Group of Eight (G8) Industry Guide 5Pharmaceuticals - Global Group of Eight (G8) Industry Guide 6Pharmaceuticals - Global Group of Eight (G8) Industry Guide 7Pharmaceuticals - Global Group of Eight (G8) Industry Guide 8Pharmaceuticals - Global Group of Eight (G8) Industry Guide 9Pharmaceuticals - Global Group of Eight (G8) Industry Guide 10Pharmaceuticals - Global Group of Eight (G8) Industry Guide 11Pharmaceuticals - Global Group of Eight (G8) Industry Guide 12Pharmaceuticals - Global Group of Eight (G8) Industry Guide 13Pharmaceuticals - Global Group of Eight (G8) Industry Guide 14
(Date:5/4/2015)... The National Association of Professional Women ... a 2015-2016 inductee into the NAPW VIP Woman of ... distinction for leadership in healthcare. NAPW is the nation's ... than 700,000 members and over 200 operating Local Chapters. ... group of professional women,” says NAPW President Star Jones. ...
(Date:5/4/2015)... The National Association of Professional Women ... 2015-2016 inductee into the NAPW VIP Woman of the ... for leadership in oral healthcare. NAPW is the nation's ... than 700,000 members and over 200 operating Local Chapters. ... group of professional women," said NAPW President Star Jones. ...
(Date:5/4/2015)... Every Friday afternoon at A Forever Recovery, ... Michigan, patients and staff gather in the common room ... program and to gain encouragement and inspiration in their ... by one, those patients who have completed their recovery ... and to share a bit about their journey with ...
(Date:5/4/2015)... The American Council of Engineering Companies ... Stanley Consultants , to the Institute of ... three-year term. , ACEC co-established ISI with the American ... Civil Engineers (ASCE). A non-profit group, ISI developed ... called Envision. Launched in 2012, the Envision rating system ...
(Date:5/4/2015)... 2015 Malibu Biotech Systems LLC ... spray. KissSafe™ is the first personal hygiene product ... while adding fresh breath appeal. KissSafe™ contains an ... germs in the mouth and oral cavity before ... that possess additional wellness benefits. KissSafe’s proprietary prevent-tech ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Jennifer Yates Doherty, Owner of Palmetto Rehabilitation Services, LLC, into its 2015 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Elizabeth Moncada, Owner, Moncada Center for Orofacial Pain, into its 2015-2016 VIP Woman of the Year Circle 2Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2Health News:Thomopulos Appointed to Institute for Sustainable Infrastructure Board 2Health News:80 Million Germs from Kissing - Introducing KissSafe™ 2
... Corporation,(Pink Sheets: GCHC.PK) announced the formation of TongRenTang ... new company, which is,owned equally by the two ... treatments and products based upon China,s famous,TongRenTang herbal ... Qigong, reflexology and many other oriental,treatments as well ...
... Advisors Transitioning to Independence, SAN FRANCISCO, ... new relationship with national human resources,outsourcing company ... for,independent investment advisors and their employees. As ... advisors who custody,assets with Schwab will now ...
... Va., Oct. 15 Sallie Mae employees,were recognized ... Team,Messenger Award for fielding the largest team at ... of events held around the,country. (Logo: ... of 276 Sallie Mae employees, family members, and,friends ...
... Company Revenues Up 9.9% For Fiscal Year Ended 2007, ... NYER ) today reported the audited financial results for its,fiscal ... for,fiscal year ended June 30, 2007 as compared to $63,596,975 ... Company reported a net income of,$86,446 or $.02 basic net ...
... insight into the mechanisms involved in resistance to treatment ... published by Cell Press in the October issue of ... may help to identify patients who are unlikely to ... for treating these patients. , Trastuzumab is an antibody ...
... of Texas, 181,legislators are being honored with the ... accomplishments on behalf of health care,during the 80th ... created the award in 1997 to honor state ... on issues important,to hospitals and health systems. ...
Cached Medicine News:Health News:Greater China Corporation Forms TongRenTang Wellness Corporation 2Health News:Schwab Institutional Introduces Healthcare and Benefits Assistance for Independent Advisor Firms 2Health News:Schwab Institutional Introduces Healthcare and Benefits Assistance for Independent Advisor Firms 3Health News:Schwab Institutional Introduces Healthcare and Benefits Assistance for Independent Advisor Firms 4Health News:Sallie Mae Employees Receive Award for Largest National Team at Lance Armstrong Foundation Fundraising Events 2Health News:Nyer Medical Group, Inc. Reports EPS of $.02 on Record Revenues of $69.9 Million for Fiscal Year Ended 2007 2Health News:Nyer Medical Group, Inc. Reports EPS of $.02 on Record Revenues of $69.9 Million for Fiscal Year Ended 2007 3Health News:Nyer Medical Group, Inc. Reports EPS of $.02 on Record Revenues of $69.9 Million for Fiscal Year Ended 2007 4Health News:Genetic approach provides new insight into trastuzumab resistance in breast cancer 2Health News:THA Honors Nine Legislators for Contributions to Health Care 2
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: